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Abstract 
Background: Several recent studies have reported successful hydrogen (H2) production achieved via recombinant 
expression of uptake [NiFe]-hydrogenases from Hydrogenovibrio marinus, Rhodobacter sphaeroides, and Escherichia coli 
(hydrogenase-1) in E. coli BL21(DE3), a strain that lacks H2-evolving activity. However, there are some unclear points 
that do not support the conclusion that the recombinant hydrogenases are responsible for the in vivo H2 production.
Results: Unlike wild-type BL21(DE3), the recombinant BL21(DE3) strains possessed formate hydrogen-lyase (FHL) 
activities. Through experiments using fdhF (formate dehydrogenase-H) or hycE (hydrogenase-3) mutants, it was 
shown that H2 production was almost exclusively dependent on FHL. Upon expression of hydrogenase, extracellular 
formate concentration was changed even in the mutant strains lacking FHL, indicating that formate metabolism other 
than FHL was also affected. The two subunits of H. marinus uptake [NiFe]-hydrogenase could activate FHL indepen-
dently of each other, implying the presence of more than two different mechanisms for FHL activation in BL21(DE3). It 
was also revealed that the signal peptide in the small subunit was essential for activation of FHL via the small subunit.
Conclusions: Herein, we demonstrated that the production of H2 was indeed induced via native FHL activated 
by the expression of recombinant hydrogenases. The recombinant strains with [NiFe]-hydrogenase appear to be 
unsuitable for practical in vivo H2 production due to their relatively low H2 yields and productivities. We suggest that 
an improved H2-producing cell factory could be designed by constructing a well characterized and overproduced 
synthetic H2 pathway and fully activating the native FHL in BL21(DE3).
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Background
Hydrogen (H2) production via biological means has been 
considered as a potential source of alternative fuel due to 
clean and truly renewable processes [1]. Hydrogenases 
are the key enzymes in microbial H2 metabolism that cat-
alyze the reversible reduction of protons with electrons 
[2]. Certain limitations of native hydrogenase systems for 
H2 production (i.e., problems related to substrate (elec-
tron donor/acceptor) specificity, oxygen (O2) sensitiv-
ity, catalytic bias to H2 oxidation, electron partitioning, 
etc.) have been reported in microorganisms [3], and their 
properties appear to be unable to meet current needs. 
Therefore, expression and engineering of hydrogenases 
in heterologous hosts is generally accepted as the most 
influential approach to modification of enzyme qualities 
and H2 production efficiency for biotechnological appli-
cations [3, 4]. Recombinant expression of hydrogenase 
not only provides the ability to engineer the H2 metab-
olism of the host for specific purposes but also could 
facilitate basic studies on the maturation process of the 
complex metalloenzyme [4].
Escherichia coli has been widely used as a host 
microbe for protein expression [5]. This bacterium was 
also adopted for expression of recombinant hydroge-
nase in several studies, either for study of hydrogenase 
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maturation or for improvement of fermentative H2 pro-
duction by coupling to the native electron transfer system 
of E. coli [6–10]. In particular, the strain BL21(DE3) (or 
BL21), which is an optimized host for protein overexpres-
sion, can neither produce nor consume H2 (no hydroge-
nase activity) under the general culture conditions where 
K-12 derivatives do possess the abilities [11–14]. This 
observation prompted certain researchers to consider 
this strain as an ideal host for hydrogenase expression 
and testing for in vivo H2 production [12–14].
According to the composition of bimetallic active 
sites, hydrogenases are broadly classified into [FeFe]- 
and [NiFe]-hydrogenases from the standpoint of bio-
technological importance. E. coli contains four different 
[NiFe]-hydrogenases, and among those, hydrogenase-3 is 
responsible for H2 production during mixed-acid fermen-
tation [15]. This enzyme forms a formate hydrogen-lyase 
(FHL) complex together with formate dehydrogenase-H, 
one of the three formate dehydrogenases of E. coli [16].
Recently, certain studies reported that homologous 
or heterologous expression of the structural (large and 
small) subunits of uptake [NiFe]-hydrogenases resulted 
in construction of recombinant BL21(DE3) derivatives 
that are capable of producing H2 [17–19]. However, some 
unclear points arise that do not support the conclusion 
that the expressed hydrogenases are indeed responsible 
for the in vivo H2 production of the recombinant strains. 
Among these points, the most critical is that all of the 
engineered hydrogenases engage in H2 uptake (consump-
tion) and not production in their native hosts [20–22]. 
In this work, we tackle this problem using simple bio-
chemical and mutant experiments. We suggest that H2 
production in such recombinant systems is almost exclu-
sively dependent on the native FHL of E. coli, and thus, 
careful characterization of the recombinant hydrogenase 
systems in BL21(DE3) is required, especially for those 
designed for in vivo H2 production.
Results and discussion
Activation of FHL activity in recombinant strains
Several efforts have been put forth to engineer uptake 
[NiFe]-hydrogenases in BL21(DE3) strain [17–19]. 
In these studies, H2 production was demonstrated by 
expressing structural (large and small) subunits of the 
hydrogenases in the non-H2 producing E. coli strain, and 
the authors concluded that the engineered, non-native 
hydrogenases could be used as tools to enhance biohy-
drogen production in E. coli. However, a critical discus-
sion promptly arises related to the fundamental origin 
of the produced H2: (1) The engineered hydrogenases 
are engaged in H2 uptake and not in H2 production in 
their native hosts, which means that standard redox 
potentials of their respective electron acceptors (e.g., 
cytochrome b) are expected to be much higher than that 
of H2 (−420 mV) [23]. Additionally, uptake [NiFe]-hydro-
genases generally show high catalytic bias to H2 oxida-
tion [24, 25]. Thus, even if an uptake [NiFe]-hydrogenase 
is ‘wired’ to an electron transport system in E. coli, H2 
produced via the non-native pathway is not expected to 
highly accumulate in a closed batch culture system [12], 
which is in contrast to the results of high H2 accumula-
tion in the previous studies [17–19]. (2) Addition of 
hypophosphite, an inhibitor of pyruvate formate-lyase, 
abolished the H2 production in a recombinant strain 
expressing E. coli HyaBA (hydrogenase-1) [19]. Moreover, 
addition of formate greatly increased in vivo H2 produc-
tion. (3) Full maturation of the expressed hydrogenases is 
questionable because maturation of [NiFe]-hydrogenase 
further requires highly specific auxiliary proteins [26].
Putting the theoretical and the experimental clues 
together, we hypothesized that the BL21(DE3) derivatives 
produce H2 via a native FHL pathway that is activated by 
the expression of the recombinant hydrogenases. A test 
for H2 production using formate as a sole electron source 
showed that the recombinant strains with the heterolo-
gous (H. marinus HoxGK and R. sphaeroides HupSL) or 
homologous (E. coli HyaBA) hydrogenase indeed showed 
FHL activity, whereas the negative control strain with the 
parental empty vector exhibited negligible FHL activity 
as expected (Fig.  1). When we measured formate con-
sumption by the strain with H. marinus HoxGK, it was 
found that the cells consumed 1.6  ±  0.1  mM formate, 
Fig. 1 FHL activation in E. coli BL21(DE3). Recombinant cells harbor-
ing each hydrogenase were cultured in PBS buffer supplemented 
with 20 mM sodium formate, and H2 production from formate was 
measured after 13 h. H.ma, Hydrogenovibrio marinus; R.sp, Rhodobac-
ter sphaeroides; E.co, Escherichia coli; (−), negative control strain with 
parental empty vector (pTrcHis C)
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whose corresponding calculated H2 production (3.58 mL) 
well coincides with the actual amount of H2 production 
(3.23 mL). In contrast, the negative control cells showed 
virtually no consumption of formate (0.0  ±  0.1  mM). 
These results imply that the FHL pathway was at least 
partially responsible for the observed in vivo H2 produc-
tion in the previously reported recombinant strains.
FHL dependency of H2 production in the recombinant 
strains
Measurement of FHL activity was not sufficient to decide 
whether H2 production in the recombinant strains origi-
nates exclusively from the activated FHL pathway. To 
examine the FHL-dependency, we constructed two 
knockout BL21(DE3) strains lacking formate dehydro-
genase-H (fdhF) and hydrogenase-3 (hycE), respectively, 
both of which constitute essential components of the 
FHL complex [16] and subsequently tested in  vivo H2 
production by expressing the recombinant hydrogenases.
In the case of the fdhF mutant, all mutant strains pro-
duced small amounts of H2 that were roughly compara-
ble to that of the negative control (Fig. 2), which clearly 
demonstrated that H2 was produced from formate as the 
only major substrate in the previous reported recombi-
nant strains [17–19]. Similarly, insignificant amounts 
of H2 were produced by hycE mutants, which indicates 
that hydrogenase-3 was almost entirely responsible for 
H2 production in the reported BL21(DE3) derivatives 
(Fig. 2). Although H2 production by both of the mutants 
with H. marinus HoxGK was slightly exceptional (2.1-
fold for fdhF mutant and 7.5-fold for hycE mutant com-
pared with the negative controls), the amounts can still 
be considered marginal compared with the positive con-
trol. It appears that the expression of HoxGK influenced 
the other E. coli hydrogenase system(s) to evolve H2 
because H2 was not detected when the E. coli MW1001 
strain lacking hydrogenase-1, hydrogenase-2, and hydro-
genase-3 was transformed with pTrcHoxGK (data not 
shown). Thus, we concluded that H2 was produced 
almost exclusively via the activated FHL pathway in the 
BL21(DE3) strains with the recombinant hydrogenases. 
We strongly suspect that the recent report on H2 produc-
tion in BL21(DE3) by expression of Rhodopseudomonas 
palustris [NiFe]-hydrogenase [27] falls within this cate-
gory. It is noteworthy that all recombinant [NiFe]-hydro-
genases that activated FHL belong to Group 1 according 
to the widely used classification of hydrogenases [28].
After in  vivo H2 production in the wild-type and the 
mutant BL21(DE3) strains with H. marinus HoxGK, 
extracellular formate concentrations were measured and 
compared with those of negative controls (Table 1). All of 
the strains with the parent vector showed similar formate 
level regardless of the FHL mutations. This is not surpris-
ing because formate consuming pathways are already 
impaired in BL21(DE3) [11]. On the other hand, when H. 
marinus HoxGK was expressed, the formate concentra-
tion of wild-type BL21(DE3) was lower than those of the 
mutant strains, indicating that formate was consumed 
for H2 production. Notably, the overall formate level was 
lowered upon the expression of hydrogenase even in the 
mutants that cannot produce H2, which implies that for-
mate metabolism (either production or consumption) 
other than FHL pathway was also affected by the expres-
sion of recombinant hydrogenase.
Involvement of each subunit in FHL activation
In an effort to reveal the role of uptake [NiFe]-hydro-
genase in FHL activation, we investigated the contribu-
tion of each subunit to H2 production using H. marinus 
hydrogenase as a model enzyme. Expression vectors were 
constructed for five different combinations of the large 
subunit (HoxG), small subunit (HoxK), and small subu-
nit without signal peptide (HoxK*) (Fig.  3a), and all of 
the subunits with His6-tag were successfully expressed 
in E. coli BL21(DE3) (Fig. 3b). As shown in Fig. 3c, dif-
ferent amounts of H2 were produced by the different 
Fig. 2 H2 production in FHL-deficient mutant BL21(DE3) strains. 
Strains lacking formate dehydrogenase-H or hydrogenase-3 were 
used. H.ma, Hydrogenovibrio marinus; R.sp, Rhodobacter sphaeroides; 
E.co, Escherichia coli; (−), negative control mutant with paren-
tal empty vector (pTrcHis C); (+), positive control strain with R. 
sphaeroides HupSL
Table 1 Extracellular concentration of formate (mM) meas-
ured after in vivo H2 production in BL21(DE3) derivatives
Plasmid Strain
Wild-type ΔfdhF ΔhycE
pTrcHis C 15.9 ± 0.3 16.5 ± 0.1 16.1 ± 0.4
pTrcHoxGK 10.6 ± 0.2 13.3 ± 1.1 13.1 ± 1.4
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combinations. This pattern of H2 production was well 
correlated with FHL activity (R2 > 0.99) (Fig. 3d), imply-
ing that the different amounts of H2 production was 
due to different degrees of FHL activation. Intriguingly, 
H2 production was observed in the recombinant strains 
with HoxG or HoxK alone (Fig. 3c). Because the catalytic 
active site of [NiFe]-hydrogenase is located in large subu-
nit [28], the result of H2 production with only the small 
subunit corroborates the previous conclusion that the 
recombinant hydrogenase was not the catalyst that pro-
duced H2 in BL21(DE3). Notably, the effects of the two 
subunits seemed to be additive (Fig. 3c), possibly repre-
senting the presence of more than two separate mecha-
nisms for FHL activation. The fact that H2 was produced 
with HoxG alone also supports this possibility.
The deletion of signal sequence on HoxK resulted in 
no H2 production, indicating that the signal peptide 
was essential for FHL activation via the small subunit 
(Fig.  3c). This observation is consistent with the previ-
ous report, in which the importance of signal peptide on 
in vivo H2 production was shown [17]. Because the signal 
peptide is implicated in the interaction with membrane 
component(s) for protein translocation [29], it is likely 
that the mechanism by which the small subunit activates 
FHL involves a membrane component that directly or 
indirectly affects FHL, which is also a membrane protein 
complex [16].
A recent study on metabolic deficiencies of BL21(DE3) 
suggested that the lack of FHL activity in BL21(DE3) can 
be restored by complementation of a wild type copy of 
fnr gene and a high concentration of metal ions (500 μM 
nickel and 1 mM molybdenum) [11]. In our experiments, 
no additional ions were added except for 30 μM nickel 
and iron, and little possibility exists that the expressed 
subunits can function as FNR. Additionally, the effect of 
FHL restoration by FNR was only partial when compared 
with the FHL activity of E. coli K-12 strains [11]. Intrigu-
ingly, an fnr mutant of K-12 strain (PB1000) still pos-
sessed 20 % FHL activity of the parent strain [11]. Thus, 
although we do not offer any clear explanation of how 
the subunits activate FHL, we suggest the existence of an 
unknown pathway(s) for FHL activation and regulation 
Fig. 3 Combinatorial expressions of hydrogenase subunits of H. marinus in BL21(DE3). a Construction of expression vectors. The constructed vec-
tors (from top to bottom) are pTrcHoxG, pTrcHoxK, pTrcHoxGK, pTrcHoxGK*, and pTrcHoxK*, respectively. b Western blot analysis. Anti-His6 antibody 
was used. c H2 production. d FHL activation. H2 production from formate was measured after 18-h incubation. RBS ribosome binding site, His6 
hexahistidine tag sequence, SP sequence for signal peptide, HoxK* HoxK without signal peptide
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of formate metabolism that is distinct from the fnr-medi-
ated activation.
Implications for future research
The main purpose of engineering hydrogenase or its rel-
evant pathway is to enhance H2 yield and/or productivity. 
Because H2 production in the recombinant BL21(DE3) 
strains almost entirely depends on native FHL, in prin-
ciple, the yield cannot exceed the theoretical maximal 
H2 yield from formate (2  mol-H2/mol-glucose) that has 
been almost realized with E. coli K-12 mutant (Table 2). 
In terms of productivity, the recombinant strains are also 
much less effective than previously constructed K-12 
derivatives (Table  2). Therefore, in their present form, 
the reported BL21(DE3) strains with the recombinant 
uptake [NiFe]-hydrogenases appear to be poorly suited 
for practical in  vivo H2 production unless non-native 
FHL-independent H2 pathways are constructed with the 
recombinant hydrogenases using synthetic biology and/
or metabolic engineering approaches. Thus, we sug-
gest that recombinant hydrogenase systems designed for 
in vivo H2 production should be carefully characterized, 
especially if E. coli BL21(DE3) is used as a host; mere 
observation of in vivo H2 production doesn’t imply suc-
cessful construction of non-native H2 pathway.
E. coli BL21(DE3) is an important strain as a general 
choice for overexpression of recombinant proteins [5] 
and holds promise for metabolic engineering and biofuel 
production. Complete elucidation of the mechanisms 
for FHL activation in BL21(DE3) is important because it 
could enable the efficient expansion of H2 yield with high 
productivity in E. coli; H2 might be produced using more 
than two substrates simultaneously in BL21(DE3) e.g., 
via the fully activated FHL pathway and the other FHL-
independent H2 pathway that is robustly constituted by 
recombinant overexpression of H2 metabolizing enzymes 
[8].
Conclusions
In this study, the H2 production pathway was investigated 
in recombinant E. coli BL21(DE3) strains that express 
the structural subunits of uptake [NiFe]-hydrogenase 
from H. marinus (HoxGK), R. sphaeroides (HupSL), 
or E. coli (HyaBA). The recombinant strains clearly 
showed FHL activity, whereas the wild-type strain did 
not. The H2 production was not observed in the recom-
binant strains lacking fdhF or hycE, thus demonstrating 
exclusive dependence of the H2 production on activated 
native FHL. Formate level was changed upon expres-
sion of hydrogenase even in the mutant strains lack-
ing FHL, indicating that formate metabolism other than 
FHL was also affected. Through combinatorial expres-
sion of hydrogenase subunits, it was shown that each 
subunit could activate FHL independently. In addition, it 
was revealed that the signal peptide is required for FHL 
activation by the small subunit. The FHL dependence of 
the recombinant BL21(DE3) derivatives fundamentally 
limits the practical use of the strains in applications for 
biohydrogen production. A more effective system might 
be constructed by synergetic combination of an overpro-
duced synthetic H2 pathway with the fully activated FHL 
pathway in E. coli BL21(DE3).
Methods
Strains and plasmid construction
The strains, plasmids, and primers used in this study 
are listed in Table  3. All of the DNA works were per-
formed using E. coli TOP10 (Invitrogen, USA), and E. coli 
BL21(DE3) (Novagen, USA) was used for hydrogenase 
expression and H2 production. The plasmid for expres-
sion of Rhodobacter sphaeroides HupSL (pEMBTL-HJ2) 
[18] and the E. coli mutant strain MW1001 [33] were 
kindly provided by Dr. Jiho Min (Chonbuk National Uni-
versity, Jeonju, Korea) and Dr. T. K. Wood (Texas A & 
M University, Texas, USA), respectively. The vectors for 
expression of the hydrogenase subunits of Hydrogenovi-
brio marinus [34] were constructed by polymerase chain 
reaction (PCR)-based cloning procedures using genomic 
DNA of H. marinus (DSM 11271) and the listed prim-
ers with NheI, NcoI, XhoI, or PstI restriction sites. The 
PCR products were inserted into the pGEM-T Easy vec-
tor (Promega, USA) prior to subcloning into pTrcHis C 
Table 2 Comparison of H2 production by E. coli strains
Host Genetic modification H2 yield  
(mol-H2/mol-glucose)
H2 productivity  
(mL-H2/L-culture h)
References
E. coli BL21(DE3) H. marinus hoxGK 0.65 25.1 [17]
E. coli BL21(DE3) R. sphaeroides hupSL 0.28 19.7 [18]
E. coli BL21(DE3) E. coli hyaBA 0.32 12.5 [19]
E. coli BL21(DE3) R. palustris hupSL 0.32 39.9 [27]
E. coli BW25113 ΔhycA ΔhyaAB ΔhybBC ΔldhA ΔfrdAB 1.80 420.7 [30, 31]
E. coli BW25113 ΔhyaB ΔhybC ΔhycA ΔfdoG ΔfrdC ΔldhA ΔaceE 1.32 354.8 [32]
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(Invitrogen). For polycistronic expression of both hydro-
genase subunits, the primers hoxK_poly and hoxK*_poly 
were designed to contain an intergenic sequence with a 
ribosome binding site (RBS), a slightly modified portion 
of the intergenic sequence between lacZ and lacY found 
in the E. coli genome. The plasmid pTrcHoxGK was 
primarily used throughout the study for expression of H. 
marinus hydrogenase. E. coli cells were grown and main-
tained in Luria–Bertani (LB) medium (Usb Corp., USA) 
supplemented with the appropriate antibiotics (ampicil-
lin, 50 μg/mL; streptomycin or kanamycin, 10 μg/mL) at 
37 °C in a shaking incubator at 220 rpm (Jeiotech, Korea).
Table 3 E. coli strains, plasmids, and primers used in this study
a Regions that hybridize to the corresponding template sequences are bolded, and restriction sites are underlined
Strains, plasmids, or primers Genotypes, relevant characteristics, or sequences Source or 
references
Strains
 TOP10 F− mcrA Δ(mrr-hsdRMS-mcrBC) Ф80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu) 7697 galU galK  
rpsL (StrR) endA1 nupG, streptomycin-resistant
Invitrogen
 BL21(DE3) F- ompT hsdSB(rB
− mB
−) gal dcm λ(DE3), carrying the T7 RNA polymerase gene Novagen
 JH0 BL21(DE3) ΔfdhF::FRT-kan-FRT This study
 JH1 BL21(DE3) ΔhycE::FRT-kan-FRT This study
 MW1001 lacIq rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 ΔhyaB ΔhybC ΔhycE [33]
Plasmids
 pGEM-T Easy bla lacZ, TA cloning vector Promega
 pEMBTL-HJ2 Expression vector with T7 promoter carrying R. sphaeroides hupS and hupL [18]
 pTrc-EcH1ABHis Expression vector with trc promoter carrying E. coli hyaB and hyaA [19]
 pTrcHis C pBR322 ori bla lacIq, a parental expression vector with trc promoter Invitrogen
 pTrcHoxGK pTrcHis C carrying H. marinus hoxG and hoxK This study
 pTrcHoxG pTrcHis C carrying H. marinus hoxG This study
 pTrcHoxK pTrcHis C carrying H. marinus hoxK This study
 pTrcHoxGK* pTrcHis C carrying H. marinus hoxG and hoxK without signal sequence This study
 pTrcHoxK* pTrcHis C carrying H. marinus hoxK without signal sequence This study
 pKD46 bla γ β exo araC, Red recombinase vector containing temperature-sensitive replicon CGSC
 pKD13 bla FRT-kan-FRT, template plasmid used for Red recombination CGSC
Primersa
 hoxG Forward: GCTAGCATGAGCGTATTAAACACACC (NheI)
Reverse: CTCGAGTTATCGAACCTTGACGGT (XhoI)
This study
 hoxK_poly Forward: CTCGAGTCTGCCCGTATTGCGCGTAAGGAAATCCATTATGTCAT CTCAAGTTGAAAC (XhoI)
Reverse: CTGCAGTCAATGGTGATGGTGATGATGACCGCCTTTATCTCCTT TCTTTTGAGCC (PstI)
This study
 hoxK*_poly Forward: CTCGAGTCTGCCCGTATTGCGCGTAAGGAAATCCATTATGGCG AACAAAATTGCTCATGC 
GAT (XhoI)
Reverse: ditto
This study
 hoxK Forward: CCATGGGCTCATCTCAAGTTGAAACGTT (NcoI)
Reverse: ditto
This study
 hoxK* Forward: CCATGGGCAACAAAATTGCTCATGCGAT (NcoI)
Reverse: ditto
This study
 fdhF13 Forward: CAATCACGTACTGCTCGGCGGCGCGCTGATCGGCGATCGGCTCG ACGCGCATTCCGGGG 
ATCCGTCGACC
Reverse: TCCTGACCCCGCGCCTGAAAACCCCCATGATCCGTCGCCAGCGT GGCGGCTGTAGGCT 
GGAGCTGCTTCG
This study
 hycE13 Forward: TTTTTGATAAAGGTAAACATGGCGATTCCTTATTTCAGCGGCGA GTTTTTATTCCGGGG 
ATCCGTCGACC
Reverse: TTAGCGTTCGTCTCCTTGCTGGCGGCGTGATTAAAGAGAGTTTG AGCATGTGTAGGCTGG 
AGCTGCTTCG
This study
 fdhFchk Forward: GTAGGGAGTAACCAGTATAA
Reverse: AATGACCCCACATAAAATGT
This study
 hycEchk Forward: CCAGCGGATAAGACGAGGT
Reverse: CGTCTTGATATTACTCCGCG
This study
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Construction of mutant strains
The Red recombination system with pKD46 (Coli Genetic 
Stock Center (CGSC), USA) was adopted for inactivation 
of chromosomal fdhF or hycE gene in E. coli BL21(DE3). 
A gene construct composed of kanamycin resistance 
gene (kan) flanked by FLP recognition target (FRT) sites 
on pKD13 (CGSC) was amplified by PCR using fdhF- or 
hycE-specific primers with 50-nt homology extensions. 
Gene disruption was performed as described in [35] 
and confirmed by PCR using specific primers that were 
designed based on the sequences flanking the disrupted 
region of the genome. The kan gene was not cured to 
avoid contamination in cell culture.
In vivo H2 production
The recombinant E. coli BL21(DE3) derivatives trans-
formed with the expression vectors were cultured in 
100  mL of M9 media (6  g/L Na2HPO4, 3  g/L KH2PO4, 
1 g/L NH4Cl, 0.5 g/L NaCl, 2 mM MgSO4, and 100 μM 
CaCl2) supplemented with 5  g/L of casamino acids (BD 
Bioscience, USA), 5  g/L of glucose, and 50  μg/mL of 
ampicillin (and 10 μg/mL of kanamycin only for mutant 
strains) in 165-mL serum bottles (Wheaton, USA) at 
37  °C and 220 rpm. When the cell density reached ~0.6 
OD at 600 nm, the cultures were induced for hydrogenase 
expression and H2 production with the addition of 1 mM 
isopropyl-β-d-thiogalactopyranoside (IPTG; Carbosynth, 
UK), 30 μM NiSO4, and 30 μM FeSO4. The bottles were 
tightly sealed with rubber stoppers and aluminum caps 
and cultivated for a further 16  h until H2 production 
was measured using gas chromatography (GC; Younglin 
Instrument, Korea).
FHL activity assay
After in vivo H2 production, cells were harvested by cen-
trifugation at 4  °C and 4000×g for 10  min and washed 
with phosphate buffered saline (PBS; 8 g/L NaCl, 1.44 g/L 
Na2HPO4, 0.2  g/L KCl, and 0.24  g/L KH2PO4; pH 7.4). 
They were resuspended in 98  mL of PBS in the serum 
bottle with addition of 2  mL of 1  M sodium formate. 
Immediately after brief (~3 min) flushing with N2 gas, the 
bottle was sealed with a rubber stopper and an aluminum 
cap. After incubation at 37 °C and 220 rpm, the produc-
tion of H2 from formate was analyzed from the gas phase 
of the bottle via GC.
H2 production measurement
The H2 production was measured as previously described 
[36]. In brief, a specific volume (usually 100 μL) of gas 
was sampled from the headspace of culture bottle and 
analyzed by GC to determine the partial H2 pressure. 
The total amount of H2 was calculated by multiplying the 
H2 concentration by the headspace volume of the bottle 
(65 mL).
Western blot analysis
Western blot analysis was performed for detection 
of hexahistidine (His6)-tagged proteins as previously 
described [36].
Formate measurement
Formate was measured by enzymatic assay using formate 
dehydrogenase as previously described [37] with slight 
modifications. Samples were diluted 1/10 with deionized 
water. A reaction solution containing 610 μL of 80 mM 
sodium phosphate buffer (pH 7.0), 300 μL of 10 mM nic-
otinamide adenine dinucleotide (NAD+; Sigma-Aldrich, 
USA) and 100 μL of formate dehydrogenase (~1  mg/
mL; Sigma-Aldrich) was mixed with 25 μL of the diluted 
sample solution. After 2.5 h reaction at 37 °C, the absorb-
ance change by formate-dependent NAD+ reduction was 
measured at 340 nm. Formate concentration was calcu-
lated based on the absorbance change and a standard 
curve prepared using sodium formate solutions (Sigma-
Aldrich) with various concentrations.
Authors’ contributions
BHJ and HJC designed the research. BHJ performed the experiments and ana-
lyzed the data. BHJ and HJC wrote the paper. Both authors read and approved 
the final manuscript.
Acknowledgements
This work was supported by the Energy Efficiency and Resources Core Tech-
nology Program of the Korea Institute of Energy Technology Evaluation and 
Planning (KETEP) grant funded by the Korea government Ministry of Trade, 
Industry and Energy (20142020200980).
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 12 July 2015   Accepted: 16 September 2015
References
 1. Lee HS, Vermaas WFJ, Rittmann BE. Biological hydrogen production: 
prospects and challenges. Trends Biotechnol. 2010;28:262–71.
 2. Mertens R, Liese A. Biotechnological applications of hydrogenases. Curr 
Opin Biotechnol. 2004;15:343–8.
 3. Rousset M, Liebgott P. Engineering hydrogenases for H2 production: 
bolts and goals. In: Zannoni D, Philippis RD, editors. Microbial BioEnergy: 
hydrogen production. Dordrecht Netherlands: Springer; 2014. p. 43–77.
 4. English CM, Eckert C, Brown K, Seibert M, King PW. Recombinant and 
in vitro expression systems for hydrogenases: new frontiers in basic and 
applied studies for biological and synthetic H2 production. Dalton Trans. 
2009;45:9970–8.
 5. Terpe K. Overview of bacterial expression systems for heterologous 
protein production: from molecular and biochemical fundamentals to 
commercial systems. Appl Microbiol Biotechnol. 2006;72:211–22.
Page 8 of 8Jo and Cha  Microb Cell Fact  (2015) 14:151 
 6. Wells MA, Mercer J, Mott RA, Pereira-Medrano AG, Burja AM, Radianing-
tyas H, et al. Engineering a non-native hydrogen production pathway 
into Escherichia coli via a cyanobacterial [NiFe] hydrogenase. Metab Eng. 
2011;13:445–53.
 7. Sun JS, Hopkins RC, Jenney FE, McTernan PM, Adams MWW. Heterolo-
gous expression and maturation of an NADP-dependent [NiFe]-hydroge-
nase: a key enzyme in biofuel production. PLoS One. 2010;5:e10526.
 8. Ghosh D, Bisaillon A, Hallenbeck PC. Increasing the metabolic capacity of 
Escherichia coli for hydrogen production through heterologous expres-
sion of the Ralstonia eutropha SH operon. Biotechnol Biofuels. 2013;6:122.
 9. Akhtar MK, Jones PR. Construction of a synthetic YdbK-dependent 
pyruvate:H2 pathway in Escherichia coli BL21(DE3). Metab Eng. 
2009;11:139–47.
 10. Kim YM, Cho HS, Jung GY, Park JM. Engineering the pentose phosphate 
pathway to improve hydrogen yield in recombinant Escherichia coli. 
Biotechnol Bioeng. 2011;108:2941–6.
 11. Pinske C, Bonn M, Kruger S, Lindenstrauss U, Sawers RG. Metabolic defi-
ciences revealed in the biotechnologically important model bacterium 
Escherichia coli BL21(DE3). PLoS One. 2011;6:e22830.
 12. Veit A, Akhtar MK, Mizutani T, Jones PR. Constructing and testing the ther-
modynamic limits of synthetic NAD(P)H:H2 pathways. Microb Biotechnol. 
2008;1:382–94.
 13. Mishra J, Khurana S, Kumar N, Ghosh AK, Das D. Molecular cloning, 
characterization, and overexpression of a novel [Fe]-hydrogenase from a 
high rate of hydrogen producing Enterobacter cloacae IIT-BT 08. Biochem 
Biophys Res Commun. 2004;324:679–85.
 14. Akhtar MK, Jones PR. Deletion of iscR stimulates recombinant clostridial 
Fe-Fe hydrogenase activity and H2-accumulation in Escherichia coli 
BL21(DE3). Appl Microbiol Biotechnol. 2008;78:853–62.
 15. Redood MD, Mikheenko IP, Sargent F, Macaskie LE. Dissecting the roles of 
Escherichia coli hydrogenases in biohydrogen production. FEMS Microbiol 
Lett. 2008;278:48–55.
 16. Sawers RG. Formate and its role in hydrogen production in Escherichia 
coli. Biochem Soc Trans. 2005;33:42–6.
 17. Kim JYH, Jo BH, Cha HJ. Production of biohydrogen by heterologous 
expression of oxygen-tolerant Hydrogenovibrio marinus [NiFe]-hydroge-
nase in Escherichia coli. J Biotechnol. 2011;155:312–9.
 18. Lee SY, Lee HJ, Park JM, Lee JH, Park JS, Shin HS, et al. Bacterial hydrogen 
production in recombinant Escherichia coli harboring a HupSL hydroge-
nase isolated from Rhodobacter sphaeroides under anaerobic dark culture. 
Int J Hydrogen Energy. 2010;35:1112–6.
 19. Kim JYH, Jo BH, Cha HJ. Production of biohydrogen by recombinant 
expression of [NiFe]-hydrogenase 1 in Escherichia coli. Microb Cell Fact. 
2010;9:54.
 20. Nishihara H, Miyata Y, Miyashita Y, Bernhard M, Pohlmann A, Friedrich B, 
et al. Analysis of the molecular species of hydrogenase in the cells of an 
obligately chemolithoautotrophic, marine hydrogen-oxidizing bacterium, 
Hydrogenovibrio marinus. Biosci Biotechnol Biochem. 2001;65:2780–4.
 21. Lukey MJ, Parkin A, Roessler MM, Murphy BJ, Harmer J, Palmer T, et al. 
How Escherichia coli is equipped to oxidize hydrogen under different 
redox conditions. J Biol Chem. 2010;285:3928–38.
 22. Koku H, Eroglu I, Gunduz U, Yucel M, Turker L. Aspects of the metabolism 
of hydrogen production by Rhodobacter sphaeroides. Int J Hydrogen 
Energy. 2002;27:1315–29.
 23. Pandelia ME, Lubitz W, Nitschke W. Evolution and diversification of Group 
1 [NiFe] hydrogenases. Is there a phylogenetic marker for O2-tolerance? 
BBA-Bioenergetics. 2012;1817:1565–75.
 24. Abou Hamdan A, Dementin S, Liebgott PP, Gutierrez-Sanz O, Richaud P, 
De Lacey AL, et al. Understanding and tuning the catalytic bias of hydro-
genase. J Am Chem Soc. 2012;134:8368–71.
 25. Murphy BJ, Sargent F, Armstrong FA. Transforming an oxygen-tolerant 
[NiFe] uptake hydrogenase into a proficient, reversible hydrogen pro-
ducer. Energy Environ Sci. 2014;7:1426–33.
 26. Casalot L, Rousset M. Maturation of the [NiFe] hydrogenases. Trends 
Microbiol. 2001;9:228–37.
 27. Zhou P, Wang YM, Gao R, Tong J, Yang ZY. Transferring [NiFe] hydrogenase 
gene from Rhodopeseudomonas palustris into E. coli BL21(DE3) for improv-
ing hydrogen production. Int J Hydrogen Energy. 2015;40:4329–36.
 28. Vignais PM, Billoud B. Occurrence, classification, and biological function 
of hydrogenases: an overview. Chem Rev. 2007;107:4206–72.
 29. Mergulhao FJM, Summers DK, Monteiro GA. Recombinant protein secre-
tion in Escherichia coli. Biotechnol Adv. 2005;23:177–202.
 30. Maeda T, Sanchez-Torres V, Wood TK. Hydrogen production by recombi-
nant Escherichia coli strains. Microb Biotechnol. 2012;5:214–25.
 31. Kim S, Seol E, Oh YK, Wang GY, Park S. Hydrogen production and meta-
bolic flux analysis of metabolically engineered Escherichia coli strains. Int J 
Hydrogen Energy. 2009;34:7417–27.
 32. Maeda T, Sanchez-Torres V, Wood TK. Enhanced hydrogen production 
from glucose by metabolically engineered Escherichia coli. Appl Microbiol 
Biotechnol. 2007;77:879–90.
 33. Maeda T, Sanchez-Torres V, Wood TK. Escherichia coli hydrogenase 3 is a 
reversible enzyme possessing hydrogen uptake and synthesis activities. 
Appl Microbiol Biotechnol. 2007;76:1035–42.
 34. Jo BH, Hwang BH, Cha HJ. Draft genome sequence of Hydrogenovibrio 
marinus MH-110, a model organism for aerobic H2 metabolism. J Biotech-
nol. 2014;185:37–8.
 35. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes 
in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 
2000;97:6640–5.
 36. Jo BH, Kim JYH, Seo JH, Cha HJ. Oxygen-dependent enhancement of 
hydrogen production by engineering bacterial hemoglobin in Escherichia 
coli. Int J Hydrogen Energy. 2014;39:10426–33.
 37. Triebig G, Schaller KH. A simple and reliable enzymatic assay for the 
determination of formic acid in urine. Clin Chim Acta. 1980;108:355–60.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
